These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2650067)

  • 1. Effective use of 15-deoxyspergualin in kidney transplantation.
    Koyama I; Kadokura M; Hoshino T; Omoto R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1088-9. PubMed ID: 2650067
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive effect of deoxyspergualin on acute renal allograft rejection in dogs.
    Fukao K; Otsuka M; Iwasaki H; Yuzawa K; Iwasaki Y
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1090-3. PubMed ID: 2650068
    [No Abstract]   [Full Text] [Related]  

  • 3. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract]   [Full Text] [Related]  

  • 4. 15-Deoxyspergualin: a powerful rescue drug for rejection in canine kidney grafting.
    Niiya S; Suzuki S; Hayashi R; Watanabe H; Itoh J; Amemiya H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1076. PubMed ID: 2650065
    [No Abstract]   [Full Text] [Related]  

  • 5. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates.
    Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B
    Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 15-deoxyspergualin on experimental organ transplantation.
    Todo S; Murase N; Kahn D; Pan CE; Okuda K; Cemej S; Casavilla A; Mazzaferro V; Ghalab A; Rhoe BS
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):233-6. PubMed ID: 3279614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxyspergualin as an immunosuppressive agent in dogs.
    Amemiya H; Suzuki S; Manabe H; Fukao K; Iwasaki Y; Dohi K; Isono K; Orita K; Yamanaka N
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):229-32. PubMed ID: 3279613
    [No Abstract]   [Full Text] [Related]  

  • 8. A new immunosuppressive agent, 15-deoxyspergualin, in dog renal allografting.
    Amemiya H; Suzuki S; Niiya S; Fukao K; Yamanaka N; Ito J
    Transplant Proc; 1989 Jun; 21(3):3468-70. PubMed ID: 2662490
    [No Abstract]   [Full Text] [Related]  

  • 9. Histologic findings in acute renal allograft rejection with triple drug immunosuppressive therapy: a retrospective analysis.
    Moreno RF; Pallardo LM; Garcia J; Sanchez J; Rochera A; Cabezuelo J; de Agustin PP
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):5-6. PubMed ID: 3051590
    [No Abstract]   [Full Text] [Related]  

  • 10. Administration schedule of 15-deoxyspergualin and combination therapy with cyclosporin A in rat tail skin transplantation.
    Dickneite G; Schorlemmer HU; Racenberg J; Sedlacek HH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1097-8. PubMed ID: 2650069
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
    Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
    Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effect of 15-deoxyspergualin and cyclosporin A in pancreatic transplantation.
    Schubert G; Stoffregen C; Loske G; Timmermann W; Schang T; Thiede A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1096. PubMed ID: 2495590
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of acute rejection episodes by deoxyspergualin (NKT-01) in dogs receiving renal allografts.
    Itoh J; Takeuchi T; Suzuki S; Amemiya H
    J Antibiot (Tokyo); 1988 Oct; 41(10):1503-5. PubMed ID: 3056896
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
    Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the new immunosuppressive agent 15-deoxyspergualin and cyclosporine A after highly allogeneic pancreas transplantation.
    Schubert G; Stoffregen C; Timmermann W; Schang T; Thiede A
    Transplant Proc; 1987 Oct; 19(5):3978-9. PubMed ID: 3313974
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
    Jiang H; Takahara S; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1992 Oct; 24(5):1726-9. PubMed ID: 1412813
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of rejection of transplanted organs.
    Keown PA; Stiller CR
    Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic use of deoxyspergualin in a quadruple immunosuppressive protocol in renal transplantation.
    Koyama I; Amemiya H; Taguchi Y; Watanabe T; Nagashima N; Suzuki S; Omoto R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1096-8. PubMed ID: 1989158
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic use of deoxyspergualin in living related renal transplantation.
    Okazaki H; Sato T; Jimbo M; Senga S; Amada N; Oguma S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1094-5. PubMed ID: 1989157
    [No Abstract]   [Full Text] [Related]  

  • 20. Deoxyspergualin: clinical experience.
    Gores PF
    Transplant Proc; 1996 Apr; 28(2):871-2. PubMed ID: 8623441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.